Download Citation
Article Source:
VS411 Reduced Immune Activation and HIV-1 RNA Levels in 28 Days: Randomized Proof-of-Concept Study for AntiViral-HyperActivation Limiting Therapeutics
Lori F,
De Forni D,
Katabira E,
Baev D,
Maserati R,
et al.
(2012)
VS411 Reduced Immune Activation and HIV-1 RNA Levels in 28 Days: Randomized Proof-of-Concept Study for AntiViral-HyperActivation Limiting Therapeutics.
PLOS ONE 7(10): e47485.
https://doi.org/10.1371/journal.pone.0047485